Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

True Leaf Medicine (C.MJ) starts the production wheels turning

Stockhouse Editorial
1 Comment| May 6, 2015

{{labelSign}}  Favorites
{{errorMessage}}

True Leaf Medicine (CSE: MJ, Stock Forum) hit another significant milestone when the company announced today that it had exclusively secured production capacities from existing pet food manufacturer, Wodema Industries.

According to the news release, the company also owns the ‘right of first refusal’ to acquire all production facilities from the Kelowna-based Wodema.

The company noted that this step falls well ahead of schedule for the April 9, 2015, release which stated that True Leaf intended to enter the $53.0 billion pet food industry with a hemp-based pet product line.

Rockstone Research has initiated coverage on the company and will publish details on the $2.7 million mirco-cap opportunity and the market for hemp in Canada and the U.S. shortly.

There is currently an article at Rockstone discussing the company, led by 30-year pet food veteran, Darcy Bomford, and chaired by former premier of British Columbia, Mike Harcourt, that can be found here.

True Leaf Medicine was in the news recently when the Vernon, British Columbia-based company was highlighted in the 4/20 medical marijuana investor power rankings penned by Stockhouse’s own MMJ guru, Chris Parry, at the end of April.

Currently there are 38.0m outstanding shares with a market cap of $2.7 million.

FULL DISCLOSURE: True Leaf Medicine is a Stockhouse Publishing client.



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company